Innovation Ecosystem

Built on China–Singapore collaboration, global networks and industry resources, Biosparc brings together the people, capabilities and partnerships needed to accelerate life sciences innovation.

Scroll More

Our Innovation Focus

We seek out and support innovation worldwide, with a focus on new modalities, next-generation therapeutics and emerging technologies, as well as AI-enabled solutions advancing healthcare and life sciences.

Next-Generation Biotech

Next-Generation Biotech

Advancing new modalities, novel therapeutic approaches and emerging biotechnologies with the potential to address unmet medical needs.

Advanced Medical Devices & Life Science Tools

Advanced Medical Devices & Life Science Tools

Supporting innovative medical devices, advanced equipment and life science tools with strong real-world applications and commercialization potential.

AI-Enabled Healthcare

AI-Enabled Healthcare

Exploring AI-enabled solutions across drug discovery, diagnostics, clinical decision-making and precision medicine.

An Ecosystem Built Around Innovators

An ecosystem is not merely a directory of resources. It takes shape when those resources are close enough, and in contact often enough, to act on one another. BioSparc builds from within the industry — bringing research, clinic, manufacturing, and capital into a shared orbit, where proximity drives collaboration and collaboration accelerates innovation.

Research Institutes

Where discovery begins

Biosparc partners with leading universities and research institutes to carry fundamental science toward industrial application. Through joint labs, technology transfer programs, and shared research platforms, breakthroughs move seamlessly from bench to venture.

Clinical Network

From bench to bedside

Access to top-tier hospitals, clinical trial centers, and globally impactful medical journals accelerates clinical validation. Biosparc connects innovators with clinical partners and trial infrastructure, turning a promising result into proven evidence.

Industry & Supply Chain Partners

Turning scientific ideas into clinical products

A curated network of trusted CROs, CDMOs, component suppliers, and manufacturing partners means companies never build alone. From preclinical services to GMP production and quality systems, Biosparc coordinates the supply chain so innovators can focus on what they do best.

Innovators

From breakthrough ideas to global impact

Biosparc brings together innovative biotech, medtech, and life sciences companies at different stages of development. By connecting them with research institutions, clinical networks, industry partners, capital, and global resources, Biosparc facilitates collaboration and helps accelerate technology development, commercialization, and international expansion.

Investors & BD Partners

Capital across the full cycle

From seed funding to growth capital, licensing deals to cross-border partnerships — Biosparc is actively building an investor network that spans the full company lifecycle. Resident companies gain direct access to venture funds, strategic corporates, and BD professionals who understand both science and markets.

AI Infrastructure AI

Intelligence built into the ecosystem

From AI-driven drug discovery platforms to computational biology tools and smart lab operations, BioSparc embeds AI capability at every layer. Shared compute resources, data platforms, and AI expertise help every resident company work faster and smarter.

Cross-border Advantage

Connecting China’s innovation capabilities with global networks to accelerate the flow of technology, capital, talent and market opportunities.

China Advantage

Strong R&D capabilities, clinical resources, and commercialization infrastructure.

Global Resources

Access to leading research, international capital, and global market opportunities.

Connecting talent, capital, technology, and industry to accelerate cross-border innovation.

Ecosystem Partners

Bringing together research institutions, healthcare organizations, investors, professional service providers, and industry partners to support innovation and growth across the life sciences ecosystem.

Innovation in Action

Discover stories of growth, collaboration and innovation across the Biosparc ecosystem.

Valued at 3.411 billion yuan ...

An infrastructure designed for the long-term evolution of life sciences. Built around innovation, collaboration ...

JiangSu, Suzhou
Sep 05, 2026

With billions in revenue as its ...

Innovent Biologics experienced a historic year in 2025. This innovative pharmaceutical company, founded in ...

JiangSu, Suzhou
Sep 04, 2026

$50 million! ICONO completes ...

Today, BioBAY-based company ICONO announced the completion of a $50 million Series C funding round ...

JiangSu, Suzhou
Sep 02, 2026

Start Your Next Stage of Growth

Join the Biosparc ecosystem and grow alongside innovators, industry partners, and global networks.

Back

Tigermed

Since its inception in 2004, Tigermed (300347.SZ / 3347.HK) has been a trusted clinical research organization that provides full-service for the global biopharmaceutical and medical device industries. We are devoted to serving our customers in their clinical development journey efficiently and cost-effectively. For twenty years, we have been accelerating the launch of innovative healthcare products with our quality, solutions, teams, experience, and expertise, to advance human health.

Visit Website